Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib at 2mg and 4mg doses improved work productivity and reduced costs for adults with atopic dermatitis.

The polyherbal emulgel is a promising treatment for rheumatoid arthritis with effective and sustained results.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.

COCs often cause nausea, vomiting, and hair loss, while Depo-Provera is linked to weight gain.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

SM04755 may be an effective topical treatment for psoriasis.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

A new cream, DHMEQ, reduces allergic skin inflammation effectively.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Cedrol promotes hair growth better than baricitinib by regulating immune cells.

Topical corticosteroids can cause serious side effects like Cushing's syndrome and hirsutism.

Curcuma aeruginosa extract lotion significantly reduces underarm hair growth.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Biorregulatory therapy significantly improved the dog's health, reversing previous issues and eliminating the need for ongoing medication.

The retired colonel's ankle swelling was caused by a reaction to the antibiotic levofloxacin.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.